To embed, copy and paste the code into your website or blog:
A federal court recently dismissed a lawsuit filed by an employee and his spouse seeking to hold his employer liable for both of them contracting COVID-19. The dismissal should bring comfort to employer anxiety over lawsuits by employees and their family members that seek damages for possibly bringing a COVID-19 infection home from the workplace due to alleged negligence by the employer.
The complaint was brought in United States District Court for the Northern District of California. As one of the first lawsuits based on this theory of liability, it alleged that the employee’s spouse contracted COVID-19 from the husband-employee, who brought it home following a COVID-19 outbreak at his workplace. They sought damages for their subsequent infection and hospitalization and alleged the employer was negligent in failing to provide a safe workspace, which caused both of their infections.
Toll free (844) 887-9500
Romeo is an energy technology company focused on designing and manufacturing lithium-ion battery modules and packs for commercial electric vehicles.
The complaint alleges that throughout the Class Period, the defendants concealed that: (1) Romeo had only two battery cell suppliers, not four; (2) the future potential risks that the defendants warned of concerning supply disruption or shortage had already occurred and were already negatively affecting Romeo s business, operations and prospects; (3) Romeo did not have the battery cell inventory to accommodate end-user demand and ramp up production in 2021; (4) Romeo s supply constraint was a material hindrance to Romeo s revenue growth; and (5) Romeo s supply chain for battery cells was not hedged, but in fact, was totally at risk and beholden to just two battery cell suppliers and the spot market for their 2021 inventory.
Friday, May 14, 2021
It’s been a year since COVID-19 caused a torrent of insurance coverage litigation regarding business interruption and extra expense coverage for losses due to governmental orders, shut down requirements, and the spread of the coronavirus. With more than 335 decisions having been issued as of early May 2021, the numbers show significantly better odds for policyholders than the insurance industry and many media reports suggest.
‘So you’re saying that there’s a chance!’
There are more than 50 decisions in which courts have either granted summary judgment to policyholders or denied insurance companies’ motions to dismiss in the context of business interruption and extra expense insurance claims resulting from the pandemic.
Investor Alert: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Securities Fraud Class Action Lawsuit Filed Against ChemoCentryx, Inc. – CCXI
05/14/2021 | 01:46pm EDT
Send by mail :
Message :
Required fields
RADNOR, Pa., May 14, 2021 (GLOBE NEWSWIRE) The law firm of Kessler Topaz Meltzer & Check, LLP reminds ChemoCentryx, Inc. (NASDAQ: CCXI) (“ChemoCentryx”) investors that a securities fraud class action lawsuit has been filed in the United States District Court for the Northern District of California against ChemoCentryx on behalf of those who purchased or acquired ChemoCentryx common stock
between November 26, 2019 and May 3, 2021, inclusive (the “Class Period”).
Lead Plaintiff Deadline:
Toll free (844) 887-9500
ChemoCentryx is a biopharmaceutical company focused on the development and commercialization of new medications targeting inflammatory disorders, autoimmune diseases, and cancer. ChemoCentryx’s lead drug candidate is avacopan.
Share:
RADNOR, Pa., May 14, 2021 (GLOBE NEWSWIRE) The law firm of Kessler Topaz Meltzer & Check, LLP reminds investors that a securities fraud class action lawsuit has been filed in the United States District Court for the Southern District of New York against Canaan Inc. (NASDAQ:CAN) ( Canaan ) on behalf of those who purchased or acquired Canaan American Depositary Receipts ( ADRs )
between February 10, 2021 and April 9, 2021, inclusive (the Class Period ).
Investor Deadline Reminder: Investors who purchased or acquired Canaan ADRs
during the Class Period may,
no later than June 14, 2021
, seek to be appointed as a lead plaintiff representative of the class. For additional information or to learn how to participate in this litigation please contact Kessler Topaz Meltzer & Check, LLP: James Maro, Esq. (484) 270-1453 or Adrienne Bell, Esq. (484) 270-1435; toll free at (844) 887-9500; via e-mail atinfo@ktmc.com;